2022
DOI: 10.1097/mbp.0000000000000615
|View full text |Cite
|
Sign up to set email alerts
|

Remote blood pressure monitoring with a wearable photoplethysmographic device in patients undergoing coronary angiography: the senbiosys substudy

Abstract: AimsThe purpose of this study is to evaluate the accuracy of the Senbiosys device in measuring blood pressure (BP) by photoplethysmography (PPG) in patients undergoing coronary angiography.Methods This is a substudy within the Senbiosys trial, which is a prospective, single-arm, single-center study, evaluating the accuracy of BP estimation of the Senbiosys device compared to invasive BP. Patients referred for coronary angiography underwent invasive BP measurement and simultaneously wore the Senbiosys ring. SBP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 19 publications
1
4
0
Order By: Relevance
“…Our device performances were comparable to the few similar studies that have investigated accuracy in a cuffless BP device, based on either ECG and PPG or PPG alone, against invasive measurements (12)(13)(14)(15). Three of these devices are available on the market (12-14)…”
Section: Discussionsupporting
confidence: 68%
See 4 more Smart Citations
“…Our device performances were comparable to the few similar studies that have investigated accuracy in a cuffless BP device, based on either ECG and PPG or PPG alone, against invasive measurements (12)(13)(14)(15). Three of these devices are available on the market (12-14)…”
Section: Discussionsupporting
confidence: 68%
“…It is however difficult to compare results from those directly due to heterogenicity. Our results demonstrated the least narrow LOA compared to SBP LOA of [−10, 10 mmHg] in 10 post cardiac surgery patients (Biobeat wrist watch) ( 13 ), [−11.9, 12.2 mmHg] in 23 ICU patients (Aktiia wrist band, PPG) ( 12 ), [−11, 16 mmHg] during cardiac catheterization in 17 patients (Senbiosys prototype finger ring, PPG) ( 15 ) and [−7.4, 12.8 mmHg] in 20 cardiac ICU patients during controlled short-term supine and in bed measurements (Vitaliti continuous vital signs monitor, ECG and PPG) ( 14 ). However, while not achieving as narrow LOA, our study had the most subjects, 25 vs. 10 (Biobeat, ECG and PPG), 23 (Aktiia), 17 (Senbiosys) and 20 (Vitaliti) and by far the largest number of pairwise comparisons of 7,327 compared to 4,000 (Biobeat), 326 (Aktiia), 708 (Senbiosys) and 120 (Vitaliti).…”
Section: Discussionmentioning
confidence: 69%
See 3 more Smart Citations